November 2021 ADUCANUMAB: WHAT NEUROLOGISTS SHOULD KNOWFeaturing: Ian M. Grant, MD
Ian M. Grant, MD, assistant professor of Neurology at Northwestern Medicine, discusses aducanumab (Aduhelm), which was approved by the FDA on June 7 for use in Alzheimer’s disease. He talks about its effectiveness and clinical impact, indication, and administration and describes important considerations for neurologists and their patients. |
Refer a PatientNorthwestern Medicine welcomes the opportunity to partner with you in caring for your patients.
|